Inhaled titanium dioxide (TiO 2 ) nanoparticles (NPs) can have negative health effects, and have been shown to cause respiratory tract cancer in rats. Inflammation has been linked to oxidative stress, and both have been described as possible mechanisms for genotoxicity of NPs, but rarely examined side-by-side in animal studies. In the present study, a wide range of complementary endpoints have been performed to study TiO 2 P25 NP-induced genotoxicity in lung overload and non-overload conditions. Additionally, lung burden, inflammation, cytotoxicity and oxidative stress have also been evaluated in order to link genotoxicity with these responses. To assess quick and delayed responses after recovery, endpoints were evaluated at two time points: 2 h and 35 days after three repeated instillations. This study confirmed the previously described lung overload threshold at approximately 200-300 cm 2 of lung burden for total particle surface area lung deposition or 4.2 ml/kg for volume-based cumulative lung exposure dose, above which lung clearance is impaired and inflammation is induced. Our results went on to show that these overload doses induced delayed genotoxicity in lung, associated with persistent inflammation only at the highest dose. The lowest tested doses had no toxicity or genotoxicity effects in the lung. In blood, no lymphocyte DNA damage, erythrocytes chromosomal damage or gene mutation could be detected. Our data also demonstrated that only overload doses induced liver DNA lesions irrespective of the recovery time. Tested doses of TiO 2 P25 NPs did not induce glutathione changes in lung, blood or liver at both recovery times.
Titanium dioxide (TiO 2 ) nanoparticles (NPs) were one of the first worldwide manufactured nanomaterials used mainly in cosmetics, coating/cleaning agents, plastics, paints, and foods (Piccinno et al., 2012) . Even if epidemiologic studies on TiO 2 provided no clear evidence of lung cancer among workers (Shi et al., 2013) , animal exposure to TiO 2 NPs has been associated with lung inflammation, lesions, fibrosis, and tumors (Heinrich et al., 1995; Pott and Roller, 2005; Shi, et al., 2013) . Thus in 2006, IARC classified TiO 2 in Group 2B, an overall evaluation of "possibly carcinogenic to humans" (IARC, 2010) .
To understand the mechanism(s) of TiO 2 NP-induced carcinogenesis in the respiratory tract, their genotoxic potential has been studied (Chen et al., 2014) . A genotoxic substance impairs the genome either by direct or indirect damage to DNA. It has been previously shown that direct primary genotoxicity of TiO 2 NPs is through direct interaction with genomic DNA (Jin et al., 2013) . Furthermore, indirect TiO 2 NP's primary genotoxicity via Reactive Oxygen Species (ROS) production-causing oxidative DNA damage, has also been shown (Creutzenberg et al., 2009; Sager et al., 2008) .TiO 2 NPs can also induce secondary genotoxicity associated with chronic inflammation (Driscoll et al., 1997b; Schins, 2013) . TiO 2 NP-induced genotoxicity has been reported to be driven by oxidative stress and/or inflammation, but exact mechanisms are still unclear due to incongruities among in vivo studies (Chen, et al., 2014; Magdolenova et al., 2014; Singh et al., 2009) . Discrepancies can be due to different TiO 2 NPs physicochemical characteristics (primary size, shape, crystal form) and study designs (dose, dispersion method, recovery time, models). Additionally, various endpoints have been used to evaluate the genotoxicity of TiO 2 NPs potential, but rarely are multiple endpoints explored in the same study, nor are the same endpoints shared among various studies (Chen, et al., 2014; Shi, et al., 2013) . Finally, TiO 2 NPs have been shown to translocate to organs such as the liver (Shinohara et al., 2014) , but reports of genotoxicity in distant organs is still rare, and warrants further examination. Genotoxicity should also be studied in association with other toxicity parameters (inflammation and oxidative stress) to understand linked responses. Inflammation has been demonstrated to be induced at doses above a lung overload threshold, defined at 200-300 cm 2 of total particle surface area lung deposition (Tran et al., 2000) or 4.2 ml/kg in volume-based cumulative lung exposure dose (Pauluhn, 2011; Pauluhn, 2014) . Thus, analyses of toxicity and genotoxicity should be conducted with doses ranging from below to above these overload thresholds (Borm et al., 2015) . TiO 2 NPs occupational exposure has been assessed up to 4.99 mg/m 3 in several industrial settings (Lee et al., 2011) . After 78 days of inhalation of TiO 2 P25 at 0.5, 2 and 10 mg/m 3 , rat lung burdens have been measured at 0.4, 1.7, and 11 mg/g lung, respectively (Bermudez et al., 2004) . Thus a 1.7 mg/g lung burden in rats should be a close approximation to a burden after inhalation at a realistic concentration (2 mg/m 3 ). In the present study, doses were chosen to range from realistic lung exposure up to overload conditions (characterized by impairment of lung particle clearance) associated with induction of lung tumors in chronic studies (Heinrich, et al., 1995) , in order to assess the link between lung overload response and genotoxicity. Thus, we chose to expose rats to 0.5, 2.5, 10 mg/kg total after inducing hyperventilation for a better distribution within lungs, by endotracheal instillation to better control the dose, and divided in three repeated exposures to reduce doserate as suggested from prior work (Driscoll et al., 2000) .
Among TiO 2 NP studies, many have worked with the commercially available AEROXIDEV R P25, demonstrating many adverse health effects (Chen, et al., 2014; Shi, et al., 2013) . Thus, P25 TiO 2 NPs were chosen for our study.
A preliminary study was performed to evaluate lung burden, clearance and biodistribution, two days after last exposure to leave time for homogeneous NP distribution within the lung, and after 92 days to assess different clearance kinetics in each dose group as previously demonstrated (Bermudez, et al., 2004) . In an attempt to resolve conflicting data, the main objective was to investigate TiO 2 NP-induced genotoxicity in overload and non-overload conditions. Cytoxicity, inflammation and oxidative stress were also assessed in order to correlate with genotoxicity. To assess toxic effects at two times, the lung, blood and liver were sampled at 2 h and 35 days after the last administration. Samples at 2 h after the last exposure enabled an assessment of immediate genotoxicity, such as primary DNA lesions, chromosomal damage, and inflammatory response. Given that 35 days after exposure allowed for enough time for cell divions, we could then estimate mutation frequency and evaluate possible delayed genotoxic effects as well as chonic inflammation.
MATERIALS AND METHODS
All chemicals were purchased from Sigma-Aldrich, unless otherwise specified.
Nanoparticles Suspensions and Characterization
TiO 2 NPs (AEROXIDEV R TiO 2 P25, 50 6 15 m 2 /g) were purchased from Evonik Industries, also named NM-105 in the Nanomaterial Testing Sponsorship Program of the Organization for Economic Cooperation and Development (OECD). Detailed physico-chemical characterization was published recently, including density at 0.13 g/cm 3 (Rasmussen et al., 2014) . We have confirmed NPs primary size with Scanning Transmission Electron Microscope (STEM CM12, lab6, electron gun 120kV, Philips) and NPs surface elemental with X-ray Photoelectron Spectrometry (XPS) (K-alpha, Thermo Scientific) (Lozano et al., 2013) . Suspensions of TiO 2 NPs were prepared just before administration. First, powder was dispersed by sonication (Cuphorn Sonicator S-4000, Misonix incorporated) for 3 min (1 min on/ 1 min off) at 15 mg/ml in ultrapure water. Then, final suspensions were diluted in PBS (Fisher Scientific). Due to a large polydispersity (Polydispersity Index between 0,3 to 0,5) Dynamic Light Scattering analyses were not relevant (Fissan et al., 2014) , thus particles agglomeration was rather analyzed with the Centrifugal Liquid Sedimentation technique (CLS) (Disc Centrifuge Particle Size Analyzer, CPS Instruments) in triplicate . Stability of final suspensions (zeta potential) were measured using a ZetasizerV R Nano ZS (Malvern).
Animals
All procedures of this study were approved by ethical committee CREMEAP (N CEA-96). Male Sprague-Dawley rats were purchased from Janvier labs, with diet and water ad-libitum, and acclimatized for 7 days before experiments. NPs treatment were subdivided in three endotracheal instillation at a 4-days interval, so NPs exposures were spread over 8 days. Each dose-group was instilled with 100 ml of vehicle (PBS 1X) or NPs suspension at 0.17, 0.83, and 3.33 mg/ml, respectively, per instillation resulting for respective treatment after three instillations in 0.5, 2.5, and 10 mg/kg or 87, 437, and 1700 cm 
Toxicity Study
Just before first treatments, peripheral blood was collected in the retro-orbital sinus. Twelve rats were gavaged with a positive control, MMS (methyl methanesulphonate) at 150 mg/kg final dose administered in three gavages at a one-day interval just before sacrifice, for comet, c-H2AX and micronucleus assays. Six rats were injected with MNU (N-methyl-N-nitrosourea) in one i.p. injection 35 days before sacrifice as positive control for the mutation assay administered at a dose of 60 mg/kg.
Forty eight rats of 10-week-old were split into four dosegroups (vehicule, low, mid, and high dose). Twenty four rats (4 x 6 rats) were sacrificed 2 h after last treatment to investigate immediate NP-induced toxicity and the other 24 rats were sacrificed 35 days after last treatment to investigate delayed NP-induced toxicity and to detect, in circulating red blood cells, mutations induced in bone marrow erythroblasts. Each euthanasia group of rats was sub-divided into two groups, three rats per each treatment group (vehicle, low dose, mid dose, high dose, and positive control groups) were treated and sacrificed concurrently following the same protocol in order to handle exposure, euthanasia, and samples analysis.
First peripheral blood was taken from the retro-orbital sinus just after euthanasia. The heart was then perfused with PBS to wash blood from organs. Broncho-Alveolar Lavages (BALs) were performed with 5 ml PBS used twice for the first two lavages. The BALs were centrifuged (450 g, 4 C, 10 min) to separate supernatant and cells, and eight other lavages were performed and discarded. Then, lung and liver were taken and immersed into dissociation buffer (HBSS, 20 mM EDTA, 10% DMSO, 4 C).
Cells suspensions were obtained by brushing organs with histobrushs (Dutscher), filtered at 60 mm and adjusted at 10 6 cells/ml with cold HBSS.
Genotoxicity: Comet, c-H2AX, Micronucleus, and Pig-a Assays
Comet Assay NP-induced DNA damage was assessed on lung, peripheral blood, and liver cells with the comet assay. Just after collection, cell suspensions and diluted blood at 1/80 with PBS were embedded in 1% Low Melting Point agarose in PBS at 37 C. The comet assay was performed as described previously (Trouiller et al., 2009) , except lysis occurred overnight. The percentage of DNA in tail was analyzed with Comet Assay IV TM software (Perceptive Instruments) using fluorescent microscope. The median of 150 tail DNA percentages was calculated per rat and used as statistical unit as recommended (Bright et al., 2011) .
Thus, lung, peripheral blood and liver cells of three rats per group migrated in the same gel and the median from two gels were pooled to obtain mean values for six rats per dose group.
c-H2AX Assay NP-induced DNA double-strand breaks (DSBs) were assessed on lung, blood lymphocytes, and liver cells with c-H2AX immunostaining. Lung cell suspensions, blood lymphocytes [from FicollPaqueV R PLUS Gradient (VWR)] and liver cell suspensions were cytospun on slides (300 rpm, 5 min) and successively immersed into paraformaldehyde (Santa-Cruz Technologies, 4%, 15min), washing buffer (PBS, 30% milk, 20% BSA, Ozyme,5 min, 3 times), lysis buffer (HBSS, Triton 0.5%, 3 min), washing buffer, into primary anti-c-H2AX antibody buffer (Merck Millipore, dilution 1/250 in washing buffer, 1 h), washing buffer, secondary antibody buffer (Alexa FluorV R 488, Invitrogen, dilution 1/500 in washing buffer, 45 min) and finally into cell nuclei staining buffer (Hoechst 5 mg/ml in ultrapure water, 15 min). Slides were then mounted with ProLongV R Diamond (Invitrogen). The number of foci in per nucleus among 100 cells was counted with fluorescent microscope and cells were grouped into four categories: 0 foci, 1-4 foci, and 4-10, >10 for analysis. Mean foci number per cell per rat were also calculated.
Micronucleus Assay NP-induced chromosomal damage was assessed on blood smears with the micronucleus test. The cells were fixed with methanol for 20 min before acridine orange staining. The number of micronucleated cells among 2000 PCE (polychromatic erythrocytes) was counted with a fluorescent microscope.
PIG-a Mutation Assay
NP-induced Pig-a mutation was assessed only on the blood of the first group of rats sacrificed at 35 days (three rats per dose groups) according to MutaFlowPLUS Kit procedures (Litron Laboratories, Rochester, NY) and as previously described (Dertinger et al., 2011) . Analysis was performed on a FACSCaliburTM flow cytometer (Becton Dickinson, San Josè , CA) with 488 nm laser. After enrichment of the analyzed sample for mutant cells, according to the kit instructions, the number of mutants was recorded relatively to a cell population of over 10 8 total red blood cells (RBC) and 10 6 reticulocytes (RET).
Cytotoxicity, Inflammation, and Oxidative Stress
Cytotoxicity NP-induced cytotoxicity was assessed on BAL and peripheral blood with LDH (lactate dehydrogenase) release which is proportional with the amount of dead or membrane-damaged cells. At 2 h and 35 days post-treatment LDH levels on BAL supernatant and serum were measured with QuantiChrom TM LDH kits (Gentaur), according to the manufacturer's recommendations. NPs cytotoxic effect was also estimated on bone marrow with ratio between polychromatic erythrocytes (PCE) and normochromatic erythrocytes (NCE), proportional with erythrocyte cell production rate. At 2 h and 35 days post-treatment the maturity of 250 PCE and NCE from methanol-fixed blood smears made for micronucleus assay, were counted. Inflammation NP-induced inflammation was assessed on the first two BAL with total cell count after May-Grü nwald/Giemsa staining (MGG) of 500 BAL cytospun cells.
NP-induced inflammation was also assessed on the first two BAL supernatant pooled together and plasma by measuring levels of interleukins (IL) 1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, keratinocyte chemoattractant-growth regulated oncogene (KC-GRO), tumor necrosis factor-a (TNF-a), and interferon-c (IFN-c) with ELISA multiplex kits (Mesoscale Discovery or MSD) according to the manufacturer's recommendations. Plates were read with the multiplex reader Sector Imager 2400V R . Luminescence was converted into pg/ml by MSD software, using cytokines standard curves.
Oxidative Stress
Total glutathione and oxidized glutathione levels were assessed in lung, blood, and liver with intracellular glutathione activity measurement following the Glutathione kit procedure (Enzo Life Sciences). The slope of reaction product appearance curve was calculated and glutathione levels were determined by comparison with calibration curves. Protein concentrations were measured for normalization purposes with Bradford assay. Samples were incubated with Bradford reagent (Biorad) for 5 min before reading at 595 nm.
Statistical analysis. The data presented is the mean of six animals 6 Standard Error of the Mean (SEM), except for PIXE (NPs TiO 2 dosage in organs) and Pig-a mutation assays, the data is mean of three animals.
Data normal distribution was checked with Shapiro-Wilk and homogeneity of variance with Levene test.
Normal distribution and homogeneity of variance were verified in PIXE data, cytokine levels, LDH activity, PCE/NCE percent, gluthation levels, Pig-a, c-H2AX, and micronuclei data.
Variance analyses in PIXE assay, cytokine levels, LDH activity, PCE/NCE ratios, gluthation levels, and mean foci c-H2AX number per cell were performed with two-way ANOVA followed by Bonferroni post-test to compare treatment groups and time groups, with an a-risk of 5% using GraphPad PrismV R software.
Variance analysis in Pig-a mutation assay was performed with one-way ANOVA followed by Bonferroni post-test to compare treatment groups, with an a-risk of 5% using GraphPad PrismV R software.
At each time point, variance analysis of c-H2AX assay per category was performed with two-way ANOVA followed by Bonferroni post-test to compare foci number per cell and treatment groups, with an a-risk of 5% using GraphPad PrismV R software.
Variance analysis of micronucleus assay performed with two-way ANOVA followed by Bonferroni post-test to compare distribution in micronuclei number before and after treatment (repeated measurement) at each time point, with an a-risk of 5% using GraphPad PrismV R software.
Nonparametric data variance of comet assay and cell counts in BAL were analyzed with Kruskal Wallis test followed by Dunn's Multiple Comparison test to compare each treated groups with this vehicle group, with an a-risk of 5% using Excel.
Regression analysis was performed (NPs dosage in lung, BAL, LDH activity, and comet assay) to estimate TiO 2 dose-response correlation.
RESULTS

Nanoparticle Characterization
TiO 2 NP suspensions were characterized using a set of complementary techniques. STEM measured TiO 2 NP primary particle diameters are in agreement with supplier data (23 6 8 nm) (Supplementary Figure 1) . Surface composition, determined with XPS a 2.6 ratio for O/Ti, similar to reported values in the literature (Rasmussen et al., 2014) , indicates that no contaminants were present. After sonication, TiO 2 NPs in PBS have nanometric sizes (Figure 1 ) distributed according to a bimodal layout including primary particles (25 6 15 nm) and 100 nm agglomerates representing 74%, 82%, and 86% in number fractions for low, mid and high doses, respectively. The rest of the population was agglomerated with sizes below 200 nm. Zeta potential means of three measurements 6 standard deviation were -30, -4, and -2 6 2 mV, respectively, for low, mid, and high doses. Lung Burden, Clearance, and Biodistribution Study
In order to confirm that exposure doses chosen from previous studies cover a minimum accumulation in lung to an overload situation, a preliminary bio-distribution study was performed, and organs including the lungs, liver, kidney and spleen, were sampled 48 h and 92 days after last exposure. For this preliminary study, time-points were different from the toxicity study to verify impaired clearance at lung overload as previously demonstrated (Bermudez, et al., 2004) . TiO 2 was found above the basal level (supplied in diet) only in the lung and liver (Figure 2 and Supplementary Table 1) . At 2 days, all administered-doses (0.5, 2.4, and 9.2 mg TiO 2 /g lung) were found in a dosedependent manner in the lung (R 2 ¼ 0.98, almost 100% of administered doses) and in the liver only at the highest dose ($10% of the administered dose). After 3 months, TiO 2 was found in the lung in a dose-dependent manner (R 2 ¼ 0.94; 0.1, 1.5, and 7.6 mg TiO 2 /g lung).
Toxicity Study
In order to compare time points, the data is presented as the mean values normalized with the mean of the corresponding vehicle control group. All raw data is presented in Supplementary  Tables 2-10 .
Genotoxicity
To evaluate genotoxic damage, the set of complementary endpoints comprise the following: (1) a comet assay to assess primary DNA damage, including single and double strand breaks, alkali-labile sites (lost base or alkylation), incomplete DNA repair sites (excision/resynthesis) and cross-links (DNAprotein or DNA-DNA), (2) c-H2AX immuno-staining assay to identify specifically DNA double-strand breaks (DSBs) on all 3 organs, (3) a micronucleus assay to quantify chromosomal damage, and (4) the Pig-a assay to estimate gene mutations in blood.
Rationale for the time points of 2 h and 35 days was detailed in the introduction.
Comet Assay DNA damage was assessed in lung, blood, and liver cells. Hedgehog percentage was analyzed, and no increase was observed in TiO 2 NP-exposed groups with respect to basal levels (data not shown). All comet assay data is the mean of two gel migrations in two independent experiments and each data set was normalized with the mean of vehicle-exposed controls migrated on the same gel (Supplementary Table 2 ). In the lung, immediately after exposure, DNA damage was statistically increased independently of TiO 2 NPs doses ( Figure 3A ), but these increases were not high enough to be biologically relevant (within historical control levels). However, after 35 days, there was a statistically and biologically significant dose-dependent DNA lesions increase at the two highest doses (R 2 ¼ 0.63). In blood immediately after exposure, TiO 2 NPs did not induce DNA lesion, however, after 35 days NPs slightly induced statistically significant DNA damage at the two high doses ( Figure 3B ), which were not biologically relevant (within historical control levels). In the liver, TiO 2 NPs increased significantly the DNA damage at the same level at the two high doses and both recovery times ( Figure 3C ). These results suggest that mid and high doses caused long-term genotoxic effects on the primary exposed organ (lung) and on a distant organ (liver), and surprisingly rapid genotoxicity on liver.
c-H2AX Assay DNA DSBs were assessed on lung, blood, and liver cells (Supplementary Table 3 ). The number of cells in each of the four categories of foci per nucleus was not different from the vehicle exposed control group, with the exception of the lung in which an increase of DSB was found immediately after exposure to the highest dose ( Figure 3D ). This result was confirmed through analysis of mean foci per cell, which was 2 foci/cell for vehicle, low and mid dose, and 4 foci/cell for the high dose. These results suggest that a high dose of TiO 2 NPs may induce DNA DSBs in the lung.
Micronucleus Assay
Chromosomal damage was assessed in blood cells ( Figure 3E ) from the same animals before and after exposure. Thus, paired statistical analysis was performed. Immediately after exposure, no statistically significant increase in the number of micronucleated cells was observed. At 35 days TiO 2 NPs induced a slight, but statistically significant, increase in micronuclei at all doses but with no dose-response relationship (Supplementary Table 4 ). It is possible that these differences might not be high enough to be biologically relevant.
FIG. 2. PIXE analyses of
Ti content means 6 SEM control levels subtracted (n ¼ 3) in lung (A) and in liver (B) day 2 (in white) and day 92 (in gray) post-treatment to 0.5, 2.5 or 10 mg/kg TiO 2 NPs. Variance analysis was performed with two-way ANOVA followed by Bonferroni post-test. Comparison with respective vehicle group is represented with ** P < 0.01, *** P < 0.001; time effect ¤¤ P < 0.01, and dose effect # P < 0.05, ## P < 0.01, ### P < 0.001.
Pig-a Mutation Assay
TiO 2 NPs mutagenicity was assessed in blood cells 35 days after exposure. Results showed that exposure to NPs did not increase the frequency of mutant red blood cells and reticulocytes (Supplementary Table 5 ).
Cytotoxicity, Inflammation, and Oxidative Stress
In order to investigate the relationship between genotoxicity and inflammation (secondary genotoxicity) and/or oxidative stress (indirect primary genotoxicity), we examined membrane permeability with lactate dehydrogenase (LDH) leakage on BAL and serum and cytotoxicity with polychromatic and normochromatic erythrocytes (PCE/NCE) numerations on blood, lung inflammatory response with broncho-alveolar lavages (BAL) numerical counts and cytokine assessment, and finally oxidative stress with glutathione content on all three organs. These parameters have been evaluated in the same animals as for genotoxic endpoints. Analyses 2 h after the last exposure enabled assessment of immediate and short-term effects; while analyses at 35 days evaluated possible persistent responses.
Cytotoxicity
In cell free BAL, a transient and dose dependent increase (R 2 ¼ 0.66) in LDH release was measured immediately after exposure but was not sustained at 35 days (Figure 4 ). In serum, LDH levels did not differ from basal levels. TiO 2 NP cytotoxic effects in bone marrow were also assessed on the basis of the percentage of blood immature erythrocytes, and no variation was observed in any exposed group relative to their control group (Supplementary Tables 6 and 7) . Cell percentages means according to foci c-H2AX number category 6 SEM in lung at 2 h were analyzed with two-way ANOVA followed by Bonferroni post-test, comparison with control group is represented with * P < 0.05 and ** P < 0.01. (E) Micronucled PCE per 1000 PCE means 6 SEM before treatment (in white) and after 35 days (in gray) were analyzed with two-way ANOVA followed by Bonferroni post-test to compare before and after treatment (repeated measurement) represented with * P < 0.05, ** P < 0.01.
FIG. 4. LDH concentration means 6 SEM normalized with respective control
group in BAL, 2 h (in white) and 35 days (in gray) post-treatment to 0.5, 2.5 or 10 mg/kg TiO2 NPs were analyzed with two-way ANOVA followed by Bonferroni post-test to compare each group with respective vehicle group represented with * P < 0.05, *** P < 0.001; time effect ¤ P < 0.05, ¤¤¤ P < 0.001, and dose effect ## P < 0.01, ### P < 0.001.
Inflammation
The total BAL cells number was not different from the control levels at either time point or any dose. At the highest dose, however, a persistent and major neutrophil increase (38-fold) linked to a decrease in macrophages was detected immediately after exposure and was still different from basal levels at 35 days (Table 1) . At the mid dose, a high variability of response from 1% to 42% of neutrophils was observed immediately after exposure. No neutrophil influx was identified at the low dose. TiO 2 NP-induced inflammation in the lung at the highest dose was confirmed with cytokine levels (Supplementary Table 8) . Indeed, pro-inflammatory cytokines IL-6, KC-GRO (IL-8 related protein in rodents) and TNF-a levels increased, while antiinflammatory cytokine IL-13 level decreased immediately after exposure (Figs. 5A-D) . After 35 days, cytokine expression was not different from the control group at any dose tested. In plasma (Supplementary Table 9 ), only the IL-6 level was increased at the highest dose, 2 h after exposure ( Figure 5E ). These results suggest an acute inflammation in lung and in plasma, which could be chronic in lung at the highest dose. Cytokine levels not different from controls were IL-1b, IL-2, IL-5 in BAL and KC-GRO in plasma. Cytokine levels below detection limits were IL-4, IFN-c, IL-10 in BAL and IL-1b, IL-2, IL-4, IL-5, IL-10, IL13, IFN-c, and TNF-a in plasma.
All together inflammation results suggest an acute inflammation in lung and in plasma, which in lung at the highest dose, could induce a chronic inflammation status as suggested by the persistent neutrophil increase.
Oxidative Stress
Total glutathione content in lung, plasma, and liver cells was not significantly different from basal levels ( Supplementary  Table 10 ). However, a decrease was observed immediately after exposure at the highest dose in lung cells and 35 days after exposure at the mid dose in liver cells but it was not statistically significant due to a large variability. Oxidized glutathione levels in lung, blood, and liver were below the detection range (data not shown).
DISCUSSION
TiO 2 P25 NPs Lung Burden, Clearance, and Biodistribution
For all doses, measured lung burdens after 3 months (20%, 63%, and 83% of initial lung burden for low, mid, and high doses, respectively) were similar to lung clearances observed in the inhalation study used for doses selection (Bermudez et al., 2004) . These comparable burdens were surprising, as it is known that instillation leads to different deposition patterns and clearances compared to inhalation (Driscoll et al., 2000; Grassian et al., 2007) . The hyperventilation performed just before the three repeated instillations may have influenced lung deposition, burden, and clearance.
Lung burden data confirmed dose selection from a minimum biopersistence to an overload situation in the lung. Lung overload, evidenced by impaired particle clearance from the lung, has been observed at the two high doses in the present study (half retention time > 60 days) (Morrow, 1988) . Due to long biopersistence of poorly soluble particles in the lung, a volumebased overload threshold was suggested at 4.2 ml/kg (Pauluhn, 2011) . Authors suggested that repeated inhalation studies should not exceed $10 ml/lung in rats that would lead to excessive retention times (Pauluhn, 2011) . For NPs, surface area was also suggested as a suitable metric to correlate lung overload linked with delayed clearance and a threshold was proposed at approximately total particle surface area lung deposition of 200-300 cm 2 in rats (Tran et al., 2000) . Both volumetric and surface area models fit our clearance data well. Indeed, only the lowest dose (87 cm 2 /lung or 1.5 ml/lung or 3.8 ml/kg) below these thresholds demonstrated normal lung clearance rate. In contrast to the mid dose (437 cm 2 /lung or 7 ml/lung or 19 ml/kg) and the high dose (1700 cm 2 /lung or 29 ml/lung or 77 ml/kg) where aletred clearance was observed, as it was also previously shown after P25 inhalation (Bermudez et al., 2004) .
In our study, a liver burden was identified at the highest dose only after 2 days exposure, but it was higher than levels detected in a previous study (10% vs 0.01% of administered dose) (Shinohara et al., 2014) . Differences could be explained due to an alternative experimental design, as only a single instillation was performed, in contrast to our study where three instillations were performed. Indeed, a recent study showed that dose-rate can influence lung clearance thus biodistribution (Baisch et al., 2014) . Overall this result suggests that a proportion of pulmonary TiO 2 NPs can quickly translocate to the liver.
TiO 2 P25 NP-Induced Inflammation
Persistent neutrophil influx at high dose and transient at the mid dose confirmed previously demonstrated inflammation after P25 inhalation and instillation in rats (Bermudez et al., 2004; Gustafsson et al., 2011; Warheit et al., 2007) . All together these data confirmed an overload threshold at 200-300 cm 2 / lung above which acute lung inflammation is induced, and a threshold at 10 ml/lung above which inflammation is persistent (Bermudez et al., 2004; Warheit et al., 2007) . Neutrophil influx just after the last exposure at 10 mg/kg was also confirmed with Neutrophils (%) 2 h 0.7 6 0.3 1 6 0.5 14 6 6 27 6 3** 35 days 0.2 6 0.1 0.4 6 0.2 2 6 0.6 8 6 2** Macrophages (%) 2 h 99 6 0.3 98 6 0.7 85 6 6* 71 6 3*** 35 days 99.5 6 0.2 99 6 0.4 98 6 0.6 91 6 3*** Lymphocytes (%) 2 h 0.6 6 0.1 0.8 6 0.3 0.6 6 0.1 1.6 6 0.7 35 days 0.3 6 0.2 0.6 6 0.4 0.2 6 0.1 1.1 6 0.7
Total BAL cells count (Â10 6 ) 2 h 2.9 6 0.8 1.9 6 0.3 4.2 6 1 4.1 6 0.6 35 days 1.8 6 0.7 2.3 6 0.4 2.3 6 0.5 1.8 6 0.3 cytokine dosage in BALs. TNF-a and IL-6 increases were also demonstrated just after instillation of high dose of P25 (Gustafsson et al., 2011; Park et al., 2009) . Consistent with our inflammation data at overload doses, previous studies have described inflammation initiation as a series of events beginning by particles-activated macrophages secreting cytokines as IL-1 and TNF-a, which in turn induce IL-8 and IL-6 release by macrophages and epithelial cells, thus stimulating inflammatory cells recruitment such as neutrophils (Bermudez et al., 2004; Driscoll et al., 1997a; Gustafsson et al., 2011; Nicod 1999; Warheit et al., 2007) . At overload, more particles can be in contact with the alveolar epithelium, which can result in a release of cytokines and create damage (Driscoll, 1996) . Cell damage, evaluated here by LDH release in lung, demonstrated increased membrane permeability, which can allow particles interstitialization, as previously shown (Bermudez et al., 2004) . The small size of NPs may facilitate uptake into cells and transcytosis across lung cells into blood and lymph circulation to reach sensitive target sites (Elder and Oberdorster, 2006) , as confirmed here with titanium measured in liver. Blood IL-6 increase due to P25 high exposure shown here confirms previous data (Gustafsson et al., 2011) . This finding could suggest that TiO 2 NPs might trigger not only local inflammation in the lungs, but also a blood inflammatory response. However, we cannot exclude a possible spillover of local pulmonary IL-6.
TiO 2 P25 NP-Induced Oxidative Stress
Inflammatory response has sometimes been associated with oxidative stress (Sager et al., 2008; Scherbart et al., 2011) , but whether ROS can trigger inflammatory responses in the respiratory tract is not yet well understood. In contrast, we found that in lung, blood, and liver cells intracellular glutathione levels were not different between NP-exposed and vehicleexposed animals at either time points and any doses. P25 NPs have only been shown to modify total glutathione content in vitro in lung cells 4 h or 24 h after high doses (Du et al., 2011; Jugan et al., 2012; Park et al., 2008) . In agreement with these data, a previous in vivo study demonstrated that P25 can induce intracellular ROS production 1, 7, and 42 days after instillation (Sager et al., 2008) . Thus, oxidative stress might be involved, but more markers should be studied in a kinetic fashion to understand its role in TiO 2 NPs toxicity in future studies.
TiO 2 P25 NP-Induced Genotoxicity
In the present study, just after exposure, P25-induced lung inflammation was not associated with DNA damage in lung cells, confirming previously published inhalation or instillation data (Lindberg et al., 2012; Rehn et al., 2003; Saber et al., 2012a; Saber et al., 2012b) . Except a mild increase of c-H2AX foci at the highest dose of P25 NPs, demonstrated here. These foci could also be due to a mild lung toxicity through apoptosis. However, one month after exposure at the highest dose (10 mg/kg), P25 NPs induced genotoxicity concomitant with persistent inflammation in the lungs (Figure 6 ), confirming previous results with high exposure to TiO 2 NPs (Hwang et al., 2010) . Inflammatory cells have been shown to induce mutagenic effects after TiO 2 inhalation exposure (Driscoll et al., 1997b) . Thus as previously suggested, TiO 2 NPs could be genotoxic to the lungs after a persistent inflammation (Magdolenova et al., 2014) . Conversely, below overload thresholds, our lowest tested dose (0.5 mg/kg) did not induce primary DNA damage in all tested organs (lung, and 35 days post-treatment (in gray) to 0.5, 2.5 or 10 mg/kg TiO2 NPs were performed with two-way ANOVA followed by Bonferroni post-test to compare with respective control group is represented with * P < 0.05, *** P < 0.001; time effect ¤ P < 0.05, ¤¤ P < 0.01, ¤¤¤ P < 0.001, and dose effect # P < 0.05, ### P < 0.001. blood, and liver) (Figure 6 ), such as previously demonstrated with low doses of P25 (Rehn et al., 2003) .
Interestingly, our mid tested dose (2.5 mg/kg), between two overload thresholds (10 ml/lung and 200-300 cm 2 /lung), induced a transient inflammation and 1 month after exposure DNA damage was noticed ( Figure 6 ). In the literature, lung inflammation has been shown to occur without genotoxicity (Lindberg et al., 2012; Rehn et al., 2003) , but lung genotoxicity without inflammation has never been shown in vivo. Our data is not sufficient to discriminate between direct and indirect primary genotoxicity, but the lack of glutathione changes could suggest a direct primary genotoxicity mechanism. This hypothesis is supported by several studies demonstrating TiO 2 NPs crossing the cell membrane (Geiser et al., 2005) and direct in vivo DNA damage through distortion of secondary DNA structure (Jin et al., 2013) . Overall, the present study demonstrated P25 NP-lung induced genotoxicity at high dose not systematically associated with inflammation. Impaired clearance kinetics can lead to more particles in contact with the epithelium that could be taken up by lung cells, then migrate into blood and lymph circulation (Elder and Oberdorster, 2006) . Our study did not show any biologically significant blood genotoxicity after P25 NPs repeated lung exposure. In contrast, repeated instillations of other TiO 2 NP induced DNA lesions on blood lymphocytes in a delayed fashion but at very high dose (Hwang et al., 2010) . Using different exposure routes, P25 have been shown to induce chromosomal damage in vivo on erythrocytes (Dobrzynska et al., 2014; Trouiller et al., 2009) . Thus, our data might be of biological significance and should be confirmed. P25 NPs did not induce gene mutations on blood cells as shown with the Pig-a mutation assay, confirming previous data after i.v. exposure (Sadiq et al., 2012) .
At higher-than-overload doses, we measured TiO 2 NPs in liver leading to DNA lesions independently of recovery times ( Figure  6 ). Liver DNA lesions have previously been found at similar doses with a different TiO 2 NP, but only one day after a single instillation (Saber et al., 2012a) . After chronic oral administration, another TiO 2 NP has also been shown to result in titanium accumulation in liver and aggregation in hepatocyte nuclei (Cui et al., 2012) . Thus, we suggest that TiO 2 NP-induced liver DNA lesions could be linked to a quick NP-translocation but a lower detection limit would be needed to better quantify NPs in liver at mid dose and after a 1 month recovery period. Rapid liver genotoxicity was unexpectedly not concomitant with lung DNA damage. Thus, high doses of P25 NPs could initially be toxic to the lungs, leading to toxicity and inflammation, while also translocating to the liver to damage DNA. Then, after 1 month, remaining NPs could be genotoxic in the lung as well as in liver.
In conclusion, the data from this study suggest that TiO 2 P25 NPs could be a potential health risk for people occupationally exposed to high concentration through the respiratory tract.
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